BR9006990A - Composicao e dose diaria de iodo elementar para tratamento terapeutico de doenca provocada por deficiencia de iodo,processo de fabricar solucao aquosa pura de iodo elementar,processo e composicao para tratar terapeuticamente endometriose,processo e composicao para tratar profilaxia de cancer de mama,solucao aquosa de iodo elementar,composicao para tratar terapeuticamente cancer de mama,embalagem comercial e composicao para tratar terapeuticamente sindrome de mama provocada por deficiencia de iodo - Google Patents

Composicao e dose diaria de iodo elementar para tratamento terapeutico de doenca provocada por deficiencia de iodo,processo de fabricar solucao aquosa pura de iodo elementar,processo e composicao para tratar terapeuticamente endometriose,processo e composicao para tratar profilaxia de cancer de mama,solucao aquosa de iodo elementar,composicao para tratar terapeuticamente cancer de mama,embalagem comercial e composicao para tratar terapeuticamente sindrome de mama provocada por deficiencia de iodo

Info

Publication number
BR9006990A
BR9006990A BR909006990A BR9006990A BR9006990A BR 9006990 A BR9006990 A BR 9006990A BR 909006990 A BR909006990 A BR 909006990A BR 9006990 A BR9006990 A BR 9006990A BR 9006990 A BR9006990 A BR 9006990A
Authority
BR
Brazil
Prior art keywords
composition
iodine
treatment
therapeutically
elementary
Prior art date
Application number
BR909006990A
Other languages
English (en)
Inventor
William R Ghent
Bernard A Eskin
Original Assignee
William R Ghent
Bernard A Eskin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by William R Ghent, Bernard A Eskin filed Critical William R Ghent
Publication of BR9006990A publication Critical patent/BR9006990A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
BR909006990A 1989-01-03 1990-01-03 Composicao e dose diaria de iodo elementar para tratamento terapeutico de doenca provocada por deficiencia de iodo,processo de fabricar solucao aquosa pura de iodo elementar,processo e composicao para tratar terapeuticamente endometriose,processo e composicao para tratar profilaxia de cancer de mama,solucao aquosa de iodo elementar,composicao para tratar terapeuticamente cancer de mama,embalagem comercial e composicao para tratar terapeuticamente sindrome de mama provocada por deficiencia de iodo BR9006990A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/292,968 US5171582A (en) 1985-07-31 1989-01-03 Treatment of iodine deficiency diseases

Publications (1)

Publication Number Publication Date
BR9006990A true BR9006990A (pt) 1991-11-12

Family

ID=23127029

Family Applications (1)

Application Number Title Priority Date Filing Date
BR909006990A BR9006990A (pt) 1989-01-03 1990-01-03 Composicao e dose diaria de iodo elementar para tratamento terapeutico de doenca provocada por deficiencia de iodo,processo de fabricar solucao aquosa pura de iodo elementar,processo e composicao para tratar terapeuticamente endometriose,processo e composicao para tratar profilaxia de cancer de mama,solucao aquosa de iodo elementar,composicao para tratar terapeuticamente cancer de mama,embalagem comercial e composicao para tratar terapeuticamente sindrome de mama provocada por deficiencia de iodo

Country Status (14)

Country Link
US (1) US5171582A (pt)
EP (1) EP0377266B1 (pt)
JP (1) JP2994741B2 (pt)
AT (1) ATE106738T1 (pt)
AU (1) AU639222B2 (pt)
BG (1) BG94738A (pt)
BR (1) BR9006990A (pt)
CA (1) CA1336889C (pt)
DE (1) DE68915987T2 (pt)
DK (1) DK128291A (pt)
ES (1) ES2057098T3 (pt)
HU (1) HUT57050A (pt)
MC (1) MC2172A1 (pt)
WO (1) WO1990007339A1 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5589198A (en) * 1985-07-31 1996-12-31 943038 Ontario, Inc. Treatment of iodine deficiency diseases
US6019970A (en) * 1985-07-31 2000-02-01 Ghent William R. Treatment of iodine deficiency diseases
US5250304A (en) * 1985-07-31 1993-10-05 Ghent William R Treatment of iodine deficiency diseases
US5955101A (en) * 1991-03-28 1999-09-21 943038 Ontario Inc. Dry starch-iodine pharmaceutical formulations
ES2114934T3 (es) * 1991-03-28 1998-06-16 Ontario Inc 943038 Formulaciones farmaceuticas secas a base de almidon/yodo.
US5910318A (en) * 1991-03-28 1999-06-08 943038 Ontario Inc. Treatment of iodine deficiency diseases
EP0722727A1 (en) * 1995-01-20 1996-07-24 Eli Lilly And Company Benzofuran derivatives for inhibiting uterine fibroid disease
US5554600A (en) * 1995-01-20 1996-09-10 Eli Lilly And Company Methods for inhibiting endometriosis
US5489587A (en) * 1995-01-20 1996-02-06 Eli Lilly And Company Benzofurans used to inhibit bone loss
US6238644B1 (en) 1997-09-03 2001-05-29 Wayne State University Method for treating and/or imaging breast cancer using radioactive iodide
US5885592A (en) * 1997-10-29 1999-03-23 Symbollon Corporation Methods and pharmaceutical compositions for oral delivery of molecular iodine
US20090214434A1 (en) * 2004-08-20 2009-08-27 O'dowd Dennis Hardy Method of detecting and treating allogenic cells responsible for endometriosis
US9511151B2 (en) 2010-11-12 2016-12-06 Uti Limited Partnership Compositions and methods for the prevention and treatment of cancer
US10988516B2 (en) 2012-03-26 2021-04-27 Uti Limited Partnership Methods and compositions for treating inflammation
US9603948B2 (en) 2012-10-11 2017-03-28 Uti Limited Partnership Methods and compositions for treating multiple sclerosis and related disorders
SG10201912301XA (en) 2013-11-04 2020-02-27 Uti Lp Methods and compositions for sustained immunotherapy
US12011480B2 (en) 2015-05-06 2024-06-18 Uti Limited Partnership Nanoparticle compositions for sustained therapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4384960A (en) * 1979-11-13 1983-05-24 Polley R D Iodine dispenser and method of dispensing iodine
US4816255A (en) * 1985-07-31 1989-03-28 Ghent William R Treatment of iodine deficiency breast syndrome
FR2611733B1 (fr) * 1987-02-26 1989-06-16 Rhone Poulenc Chimie Composition a base de gomme diorganopolysiloxane contenant de l'iode pour le traitement des eaux

Also Published As

Publication number Publication date
WO1990007339A1 (en) 1990-07-12
DK128291A (da) 1991-08-21
DE68915987T2 (de) 1995-01-12
AU4819990A (en) 1990-08-01
DE68915987D1 (de) 1994-07-14
JPH04503949A (ja) 1992-07-16
CA1336889C (en) 1995-09-05
US5171582A (en) 1992-12-15
EP0377266A1 (en) 1990-07-11
JP2994741B2 (ja) 1999-12-27
DK128291D0 (da) 1991-07-01
ATE106738T1 (de) 1994-06-15
AU639222B2 (en) 1993-07-22
ES2057098T3 (es) 1994-10-16
BG94738A (bg) 1993-12-24
EP0377266B1 (en) 1994-06-08
HUT57050A (en) 1991-11-28
HU900916D0 (en) 1991-10-28
MC2172A1 (fr) 1992-05-22

Similar Documents

Publication Publication Date Title
BR9006990A (pt) Composicao e dose diaria de iodo elementar para tratamento terapeutico de doenca provocada por deficiencia de iodo,processo de fabricar solucao aquosa pura de iodo elementar,processo e composicao para tratar terapeuticamente endometriose,processo e composicao para tratar profilaxia de cancer de mama,solucao aquosa de iodo elementar,composicao para tratar terapeuticamente cancer de mama,embalagem comercial e composicao para tratar terapeuticamente sindrome de mama provocada por deficiencia de iodo
BG105588A (en) Anthranilic acide amides and the use thereof as medicaments
ES2060883T3 (es) Procedimiento de obtencion del acido carnosico.
EG18624A (en) Process for preparing disinfecting compositions
AP2088A (en) Phenethanolamine derivatives for treatment of respiratory diseases
EP0414275A3 (en) Process for the preparation of cyclic aminoacid derivitives as well as the intermediate products
MXPA04002405A (es) Derivados de fenetanolamina para tratamiento de enfermedades respiratorias.
DE3370626D1 (en) Imidazolylalkylthienyl-tetrahydropyridazines and process for their preparation
FR2562539B1 (fr) Nouveaux derives de l'acide vinyl-4 benzoique, leur procede de preparation et leurs applications en therapeutique et comme ligands
EP1133294A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALZHEIMER'S DISEASE, DAMAGE TO THE CENTRAL NERVOUS SYSTEM AND INFLAMMATORY DISEASES
KR890701107A (ko) 알쯔하이머 병 치료용 화합물들
EP0444196A4 (en) Agent for treatment and prophylaxis of ischemic disease of heart or brain
HUT61661A (en) Process for producing pharmaceutical compositions for treating inflammatory gastrointestinal diseases
GB8621816D0 (en) Therapeutic composition
FI93117C (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 9-aminotetrahydroakridiinijohdannaisten valmistamiseksi
CA2439879A1 (en) C2,5'-disubstituted and n6,c2,5'-trisubstituted adenosine derivatives and their different uses
IL85945A0 (en) Pharmaceutical compositions containing 2'-fluoronucleosides and derivatives thereof,certain such novel compounds and their preparation
IT1169858B (it) Complessi platino-diamminici, procedtimento per la loro prreparazione,procedimento per la preparazione di una compossizione medica contenente tali complessi platino-diamminici per il trattamento del cancro,nonche' composizione cosi' realizzata
FR2651435B1 (pt)
DE3476392D1 (en) Purine derivatives
HUT62785A (en) Process for producing pharmaceutical compositions comprising trinitrobenzenes and carminic acid, suitable for treating cancer and viral diseases
IL111805A0 (en) Pharmaceutical compositions comprising dimeticone for the treatment of aphthae
DE3371515D1 (en) Cycloalkyl derivatives of benzisoselenazolones, process for their preparation and pharmaceutical compositions containing them
GB2204488B (en) Pharmaceutical compositions for the treatment or prophylaxis of skin disorders
PT84384A (en) Process for preparing isohexide nucleosides useful as medicaments

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal